Rimegepant is already FDA-approved for acute treatment of migraine and preventive treatment of episodic migraine in adults.

If you’ve ever had a migraine, you know how painful and debilitating it can be. In fact, migraine is the No. 1 disabling condition in women under age 50 and the second disabling condition for all ...

There are many effective acute and preventive migraine treatment options available today, including whole new medication ...

Emgality is FDA approved for preventing migraine attacks in adults. This article is your guide to side effects, access, and ...

BARCELONA — For the first time, new research shows that taking a specific class of migraine medication during the prodromal phase reduces the development and severity of the subsequent headache. In ...

The New England Journal of Medicine has published two separate studies showing that CGRP-targeting therapies – namely Novartis' erenumab and Teva’s fremanezumab - significantly cut the number of ...

Most patients with migraine are women, and this observation is reflected in clinical studies. A pharmacologist and a neurologist from the United States argue that the efficacy of calcitonin ...

The approval of medicines called “CGRP antagonists” has led to big changes in how migraines are managed. These medicines work in a different way than older medicines to treat or prevent migraine. The ...

Significantly reduced rate of acne and rosacea seen in patients treated with CGRPi mAbs vs triptans, topiramate. HealthDay News — For patients experiencing migraine, direct calcitonin gene-related ...

For Cherise Irons, chocolate, red wine, and aged cheeses are dangerous. So are certain sounds, perfumes and other strong scents, cold weather, and thunderstorms. Stress and lack of sleep, too. She ...

Calcitonin gene-related peptide (CGRP) inhibitors -- a group of drugs commonly used to treat migraine -- were associated with decreased rates of acne and rosacea compared with drugs that did not ...

Direct calcitonin gene-related peptide with monoclonal antibody exposure was also associated with significantly reduced rates of acne and rosacea compared with topiramate. HealthDay News — For ...